NDC product
Clindamycin phosphate and benzoyl peroxide
NDC 0591-3916 · Actavis Pharma, Inc.
Key facts
| Product NDC | 0591-3916 |
|---|---|
| Proprietary name | Clindamycin phosphate and benzoyl peroxide |
| Labeler | Actavis Pharma, Inc. |
| Marketing category | ANDA |
| Application number | ANDA205128 |
| Marketing start | Feb 19, 2019 |
| Marketing end | Jun 30, 2026 |
| Listing certified through | Jun 30, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: